|Study Description:||The goal of this clinical research study is to learn if the combination of |
lenalidomide and rituximab can help to control CLL. The safety of this drug
combination will also be studied.
Lenalidomide is designed to change the body's immune system. It may also
interfere with the development of tiny blood vessels that help support tumor
growth. This may decrease the growth of cancer cells.
Rituximab is designed to attach to cancer cells and damage them, which may
cause the cells to die.